Complete Wegovy vs Mounjaro Starter Dose Analysis
Understanding Wegovy vs Mounjaro Dosage Chart Differences for New Patients
When comparing the Wegovy vs Mounjaro dosage chart, the most striking difference lies in their starter dose approaches. Wegovy begins with an ultra-low 0.25mg dose for the first four weeks, designed to gradually introduce your body to semaglutide's GLP-1 receptor effects. This gentle introduction helps minimise initial side effects whilst allowing your digestive system to adapt to the medication's appetite-regulating mechanisms. Mounjaro, conversely, starts at 2.5mg weekly, reflecting tirzepatide's dual GIP and GLP-1 receptor targeting, which may require different tolerance considerations for first-time users.
The Wegovy vs Mounjaro dosage chart comparison reveals fundamentally different escalation philosophies. Wegovy follows a 16-week step-up protocol (0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg maintenance), with each dose level maintained for exactly four weeks to ensure optimal tolerance and effectiveness. This structured approach, validated in the STEP clinical trial programme, provides predictable progression markers for both patients and prescribers. Mounjaro's escalation follows a different timeline, moving from 2.5mg to higher doses based on individual response and tolerance, making the choice between treatments highly dependent on personal medical factors and prescriber assessment.
Wegovy Starter Dose Pricing and Bundle Options at EverydayMeds
The Wegovy vs Mounjaro dosage chart comparison extends to pricing structures, with Wegovy's 0.25mg starter dose available for £79.99 at EverydayMeds. New customers receive automatic application of code FIRST40 at checkout, whilst returning patients benefit from DOSE25 pricing. Our Intro Duo bundle (0.25mg + 0.5mg) provides your first two months' treatment for £169.99, ensuring seamless progression through the initial escalation phase without requiring separate orders. This pricing reflects the prescription-only medicine status and includes comprehensive prescriber review and next-day cold-chain delivery.
For patients seeking extended starter phase support, our Gentle Start Trio (0.25mg, 0.25mg, 0.5mg) offers £269.99 value for those requiring slower dose progression. The Wegovy vs Mounjaro dosage chart pricing comparison shows different cost structures throughout treatment, with Wegovy's gradual escalation allowing patients to experience lower monthly costs initially. Individual dose progression pricing includes 0.5mg at £94.99 (weeks 5-8), 1mg at £99.99 (weeks 9-12), and 1.7mg at £139.99 (weeks 13-16), before reaching the 2.4mg maintenance dose at £209.99 weekly. All pricing includes GPhC #9012878 registered pharmacy dispensing and clinical oversight.
Clinical Evidence Supporting Wegovy vs Mounjaro Dosage Chart Protocols
The Wegovy vs Mounjaro dosage chart protocols are both supported by extensive clinical trial evidence, though direct head-to-head comparisons remain limited due to different trial designs and populations. Wegovy's escalation schedule was established through the STEP trial programme, with STEP 1 demonstrating that patients following the standard dosage chart experienced approximately 15% average weight loss at 68 weeks when combined with reduced-calorie diet and increased physical activity. The gradual dose escalation proved crucial for maintaining treatment adherence and minimising discontinuation rates due to gastrointestinal side effects.
Research by Wilding et al., published in NEJM 2021, specifically validated Wegovy's starter dose approach, showing that the 0.25mg beginning dose allows optimal GLP-1 receptor adaptation. Mounjaro's clinical evidence stems from the SURMOUNT trial programme, demonstrating effectiveness with its different starter dose protocol. However, comparing these programmes directly would be inappropriate given different primary endpoints, study populations, and co-interventions, making individual prescriber assessment essential for determining which dosage chart suits specific patient needs.
How Wegovy's Mechanism Influences Its Dosage Chart Design
Understanding the Wegovy vs Mounjaro dosage chart requires appreciating semaglutide's specific mechanism as a GLP-1 receptor agonist. Wegovy mimics the natural incretin hormone GLP-1, binding to receptors throughout your digestive system and brain's appetite centres to promote satiety and reduce food cravings. The ultra-low 0.25mg starter dose allows these receptors to gradually adapt to increased GLP-1 activity without overwhelming your system's natural regulatory mechanisms. This gentle approach helps minimise the nausea, vomiting, and digestive discomfort that can occur when GLP-1 levels change rapidly. The systematic four-week intervals between dose increases ensure your body maintains therapeutic response whilst building tolerance, creating sustainable long-term treatment outcomes alongside reduced-calorie diet and increased physical activity.
Streamlined Ordering Process for Wegovy Starter Doses
Beginning Wegovy treatment through EverydayMeds starts with our comprehensive 3-minute online clinical assessment, designed specifically for weight management prescribing under MHRA guidelines. Our GPhC-registered prescribers review your medical history, current medications, weight management goals, and suitability for Wegovy's dosage escalation schedule within standard 3 working days (or express 24-hour review). Once approved, your 0.25mg starter dose ships via next-day delivery using temperature-controlled packaging to maintain the medication's stability and effectiveness. The process includes detailed injection guidance, side effect management advice, and clear instructions for progressing through the Wegovy vs Mounjaro dosage chart comparison you've researched. Our clinical team remains available throughout your treatment journey to address questions about dose escalation, managing side effects, or adjusting your treatment plan based on individual response and tolerance patterns.
Storage Requirements and Practical Considerations for Starter Doses
The Wegovy vs Mounjaro dosage chart comparison includes important storage differences that affect treatment convenience and travel flexibility. Wegovy pens require refrigeration at 2-8°C before first use but offer exceptional room temperature stability, remaining effective for up to 6 weeks below 30°C once removed from the fridge. This storage advantage surpasses Mounjaro's 21-day room temperature limit, providing greater flexibility for holidays, business travel, or emergency situations. The FlexTouch pen delivery system makes weekly injections straightforward, with clear dose markings and user-friendly design suitable for patients new to injectable medications. Your starter dose journey progresses predictably through the established escalation schedule, with each dose increase scheduled every four weeks to optimise both tolerance and therapeutic effectiveness whilst maintaining the prescription-only medicine safety standards required for weight management treatment.
First Month Expectations: Wegovy Starter Dose Experience vs Mounjaro
The Wegovy vs Mounjaro dosage chart comparison reveals significantly different first-month experiences for new patients beginning treatment. Wegovy's 0.25mg starter dose typically produces subtle appetite changes within the first week, with many patients noticing reduced food cravings and earlier satiety during meals without dramatic side effects. The gentle introduction allows your body to adapt gradually to semaglutide's effects, making the initial treatment phase more comfortable and sustainable. Some patients experience mild nausea or digestive changes, but the low starter dose minimises these compared to higher initial doses used in other weight management approaches.
Mounjaro's 2.5mg starter dose reflects its dual GIP and GLP-1 receptor mechanism, potentially producing more immediate appetite suppression effects alongside different tolerability considerations. When reviewing the Wegovy vs Mounjaro dosage chart with your prescriber, they'll consider your medical history, previous medication responses, and treatment goals to recommend the most appropriate starting approach. Both medications require commitment to the prescribed escalation schedule, as skipping doses or rushing progression can compromise both safety and effectiveness outcomes.
Start Your Wegovy Journey with Expert Support from EverydayMeds
Ready to begin Wegovy treatment following our comprehensive Wegovy vs Mounjaro dosage chart comparison? Your 0.25mg starter dose awaits at £79.99, with new customer code FIRST40 and returning patient code DOSE25 applied automatically at checkout for transparent pricing. Our GPhC #9012878 registered pharmacy provides complete starter support, including detailed injection tutorials, side effect management guidance, and clear progression timelines through your escalation journey. Complete your clinical assessment today at https://everydaymeds.co.uk/products/wegovy-0-25mg to begin your medically-supervised weight management programme. Our prescribers will review your suitability for Wegovy's dosage protocol and provide ongoing support throughout your treatment journey, ensuring optimal outcomes alongside your reduced-calorie diet and increased physical activity programme. Both Wegovy and Mounjaro remain available through EverydayMeds, with expert guidance to help determine which treatment approach best suits your individual needs and medical circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
